BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18167643)

  • 1. Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.
    Sheldon J; Ramos B; Garcia-Samaniego J; Rios P; Bartholomeusz A; Romero M; Locarnini S; Zoulim F; Soriano V
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):279-82. PubMed ID: 18167643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy.
    Pal A; Sarkar N; Saha D; Guha SK; Saha B; Chakrabarti S; Chakravarty R
    Antivir Ther; 2015; 20(5):545-54. PubMed ID: 25654813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues].
    Sayan M; Buğdacı MS
    Mikrobiyol Bul; 2013 Jul; 47(3):544-9. PubMed ID: 23971933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
    Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
    Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.
    Ramos B; Núñez M; Martín-Carbonero L; Sheldon J; Rios P; Labarga P; Romero M; Barreiro P; García-Samaniego J; Soriano V
    J Acquir Immune Defic Syndr; 2007 Apr; 44(5):557-61. PubMed ID: 17224847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
    Belyhun Y; Maier M; Liebert UG
    Antivir Ther; 2017; 22(2):97-111. PubMed ID: 27354181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
    J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F; Vincenti D; Vairo F; Solmone M; Mariano A; Piselli P; Puro V; Capobianchi MR; Antonucci G
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.
    Archampong TN; Boyce CL; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Blackard JT; Kwara A
    Antivir Ther; 2017; 22(1):13-20. PubMed ID: 27167598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B.
    Quarleri J; Moretti F; Bouzas MB; Laufer N; Carrillo MG; Giuliano SF; Pérez H; Cahn P; Salomon H
    AIDS Res Hum Retroviruses; 2007 Apr; 23(4):525-31. PubMed ID: 17506609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of drug resistance mutations in the HBV genome in ART-experienced HIV-coinfected patients in southwestern Nigeria.
    Akanbi OA; Harms D; Wang B; Osundare FA; Adesina O; Oluremi AS; Omoruyi EC; Kappert K; Opaleye OO; Bock CT
    Antivir Ther; 2019; 24(7):521-528. PubMed ID: 31566576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
    Sayan M; Akhan SC
    Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil.
    Silva AC; Spina AM; Lemos MF; Oba IT; Guastini Cde F; Gomes-Gouvêa MS; Pinho JR; Mendes-Correa MC
    Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):770-8. PubMed ID: 20944991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus and HIV infection.
    Martín-Carbonero L; Poveda E
    Semin Liver Dis; 2012 May; 32(2):114-9. PubMed ID: 22760650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
    Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon.
    Magoro T; Gachara G; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong P
    Virol J; 2016 Oct; 13(1):178. PubMed ID: 27769271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.
    Plaza Z; Aguilera A; Mena A; Vispo E; Sierra-Enguita R; Tomé S; Pedreira J; Rodriguez C; Barreiro P; del Romero J; Soriano V; Poveda E
    AIDS; 2013 Sep; 27(14):2219-24. PubMed ID: 23669158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.